← All indications
Communicable Diseases
An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
Subtype terms (4)
More specific conditions that are subtypes of Communicable Diseases in the MeSH hierarchy.
- Blood-Borne Infections
7 drugs approved
- Communicable Diseases, Emerging
1 drug approved
- Communicable Diseases, Imported
- Sexually Transmitted Diseases
30 drugs (27 approved, 3 experimental)
Drugs by status
Approved for this indication (4)
Phase 4 trials (12)
Phase 3 trials (21)
- vitamin d3
- iron
- allogeneic microbiota
- procaine benzylpenicillin
- doxycycline
- inactivated rabies vaccine
- hepatitis b vaccine (recombinant)
- rabies immune globulin (human)
- syn023
- ciprofloxacin
- rivaroxaban
- isopropyl alcohol
- ferritin
- hypochlorous acid
- oxygen
- moxifloxacin
- blood plasma
- vitamin a
- chlorhexidine
- favipiravir
- COVID-19 convalescent plasma
Phase 2 trials (27)
- Anecortave
- Tenofovir exalidex
- tenofovir
- hydroxychloroquine
- bovine colostrum
- menc-hib
- nu300
- p128
- pneumococcal 13-valent conjugate vaccine
- tafenoquine succinate
- yellow fever vaccine 17d strain
- inactivated japanese encephalitis vaccine
- multi-valent pneumococcal conjugate vaccine
- autologous microbiome
- inactivated influenza vaccine
- live attenuated chimeric japanese encephalitis vaccine
- measles, mumps, and rubella vaccine
- haemophilus influenzae type b conjugate vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- varicella zoster virus glycoprotein e antigen
- Lactobacillus acidophilus
- meningococcal (group B) vaccine
- rvm-v001
- Inactivated polio virus - Enhanced
- jcxh-105
- jcxh-221
- rvm-v002
Phase 1 trials (16)
Organizations
Organization Involved with Phase 4 Indications (394)
- University of Colorado, Denver
- University of Barcelona
- Wenzhou Medical University
- Humboldt University
- Osakidetza
- VLIR Institutional University Collaboration Programme
- Spaarne Gasthuis
- Shandong University of Traditional Chinese Medicine
- Nanchang University
- Instituto Nacional de Enfermedades Respiratorias
- Shenyang Pharmaceutical University
- University of Oulu
- Chinese University of Hong Kong
- Groene Hart Ziekenhuis
- National Institute of Mental Health (NIMH)
- University of Athens
- Emory University
- People's Liberation Army of China
- Ghent University
- University of Maryland
- Henry Ford Health System
- Government of Finland
- University of Lausanne
- University of Western Ontario
- George Washington University
- University of Connecticut
- Swiss Paraplegic Centre Nottwil
- Scientific Centre of Urology, Republic of Kazakhstan
- University of Alberta
- Changzhi City People's Hospital
- +364 more
Organization Involved with Phase 3 Indications (339)
- Cytoplan Ltd
- McLaren Health Care
- Ginkgo Pharma Co., Ltd.
- Melinta Therapeutics
- Taksin Hospital
- Queen Savang Vadhana Memorial Hospital, Thailand
- Innocoll
- University of Calgary
- Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
- Fischer Family Trust
- Sanpatong Hospital
- Azidus
- Summit Therapeutics
- The HIV Netherlands Australia Thailand Research Collaboration
- Griffith University
- Eastern Health, Canada
- Arpida AG
- Boehringer Ingelheim
- Miguel Hernández University
- Clinipace LTD
- University of Puerto Rico
- Excited States, LLC
- Groupe Hospitalier Paris Saint Joseph
- Centre Hospitalier de Tourcoing
- United States Agency for International Development
- University of the Philippines
- CV Therapeutics
- University of Edinburgh
- Thai Red Cross AIDS Research Centre, Bangkok, Thailand
- Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA
- +309 more
Organization Involved with Phase 2 Indications (295)
- Manhattan Eye, Ear & Throat Hospital
- Ablynx
- The Campbell Foundation
- Alcon
- Progenics
- Russian Academy of Medical Sciences
- Armata Pharmaceuticals, Inc.
- Whitman-Walker Clinic
- ViroPharma
- Changhua Christian Hospital
- University of Sydney
- Pherecydes Pharma
- PolyMedix, Inc.
- Clinica Universidad de Navarra
- CytoDyn, Inc.
- University of South Alabama
- National Research Center, Egypt
- Wake Dermatology
- Rutgers University
- Xijing Hospital
- Northwestern University
- Government of Germany
- FIT Biotech Ltd.
- Unipharm, Inc.
- The Canadian Blood and Marrow Transplant Group
- The Alfred Hospital
- Biontech
- Lytix Biopharma AS
- International AIDS Vaccine Initiative
- Government of Thailand
- +265 more
Organization Involved with Phase 1 Indications (74)
- University of Hawaii
- Purdue Pharmaceuticals
- Spring Bank Pharmaceuticals, Inc.
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Rush University
- Phagelux Inc.
- Swiss Pharma
- Government of Quebec
- Instituto de Medicina Tropical Alexander von Humboldt
- The Honolulu Medical Group
- Sangamo BioSciences
- ReiThera Srl
- Inovio Pharmaceuticals
- Argus Pharmaceuticals
- Nutra Canada
- Antiva Biosciences
- Rinati Skin, LLC
- Sandoz
- SEEK
- University of Auckland
- National Autonomous University of Mexico
- Actelion
- Tianjin Cansino Biotechnology Inc
- Tsinghua University
- Department of Defense
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- SRI International
- OXO Chemie
- Shahid Beheshti University of Medical Sciences
- SL BIGEN
- +44 more
Organization Involved with Other Experimental Indications (134)
- Uniformed Services University of the Health Sciences
- Swiss Academy of Medical Sciences (SAMS)
- UD-Genomed Kft.
- Corporacion Ecuatoriana de Biotecnologia
- Scigenia GmbH
- Sonescence, Inc.
- University of Split
- University of Tennessee, Chattanooga
- Becton Dickinson
- Lindenhofstiftung
- Technical University of Denmark
- Universidade do Vale do Sapucai
- Central University of Ecuador
- The Danish Council for Strategic Research
- United States Navy
- Government of Niger
- Universidad Autonoma de Nuevo Leon
- Procter and Gamble
- VANTXHCS
- Fraser Health
- Hospital General Dr. Manuel Gea Gonzalez
- Biofortis
- Medical University of Graz
- Hospital Corporation of America
- Sutter Health
- University of Caen-Normandie
- Islamia University of Bahawalpur
- BioGaia AB
- Mission Health, North Carolina
- Hormozgan University of Medical Sciences
- +104 more